LON:ARIX Arix Bioscience Share Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Arix Bioscience PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 103 -1.50 (-1.44 %) (As of 09/22/2020 12:00 AM ET) Add Compare Share Today's Range 101Now: GBX 103▼ 107.0250-Day Range 74.50MA: GBX 83.71▼ 10652-Week Range 57Now: GBX 103▼ 122Volume12,141 shsAverage Volume111,643 shsMarket Capitalization£139.68 millionP/E Ratio7.36Dividend YieldN/ABetaN/A ProfileAnalyst RatingsChartCompetitorsInsider TradesHeadlines Arix Bioscience plc, formerly known as Perceptive Bioscience Investments Limited, is a venture capital firm specializing in seed, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, medical innovation comprising healthcare and life sciences. It seeks to invest globally. The firm employs an evergreen approach to funding. It primarily makes investments from its own balance sheet. The firm prefers to take board seat. The firm exit when the optimum value has been reached. Arix Bioscience plc is based in London, United Kingdom with an additional office in New York, New York.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Arix Bioscience. Previous Next 2.3 Community Rank Outperform VotesArix Bioscience has received 77 “outperform” votes. (Add your “outperform” vote.)Underperform VotesArix Bioscience has received 92 “underperform” votes. (Add your “underperform” vote.)Community SentimentArix Bioscience has received 54.44% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Arix Bioscience and other stocks. Vote “Outperform” if you believe ARIX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ARIX will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldArix Bioscience does not currently pay a dividend.Dividend GrowthArix Bioscience does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Arix Bioscience insiders have not sold or bought any company stock. Previous Next 1.9 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Arix Bioscience is 7.36, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 18.40.Price to Earnings Ratio vs. SectorThe P/E ratio of Arix Bioscience is 7.36, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.63.Price to Book Value per Share RatioArix Bioscience has a P/B Ratio of 0.54. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.84 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:ARIX Previous Symbol CUSIPN/A CIKN/A Webarixbioscience.com Phone+44-20-72901050Debt Debt-to-Equity Ratio0.26 Current Ratio27.11 Quick Ratio26.83Price-To-Earnings Trailing P/E Ratio7.36 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£23.47 million Price / Sales5.95 Cash FlowGBX 32.75 per share Price / Cash Flow3.15 Book ValueGBX 192.40 per share Price / Book0.54Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees14 Outstanding Shares135,610,000Market Cap£139.68 million Next Earnings DateN/A OptionableNot Optionable GBX 103 -1.50 (-1.44 %) (As of 09/22/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive ARIX News and Ratings via Email Sign-up to receive the latest news and ratings for ARIX and its competitors with MarketBeat's FREE daily newsletter. Arix Bioscience (LON:ARIX) Frequently Asked Questions How has Arix Bioscience's stock price been impacted by COVID-19? Arix Bioscience's stock was trading at GBX 77 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ARIX shares have increased by 33.8% and is now trading at GBX 103. View which stocks have been most impacted by COVID-19. Who are some of Arix Bioscience's key competitors? Some companies that are related to Arix Bioscience include CEL-SCI (CVM), Biotest (BIO), Altimmune (ALT), iShares Diversified Alternatives Trust (ALT), Pfenex (PFNX), Pfenex (PFNX), Inventiva (IVA), IMV (IMV), Ibio (IBIO), Ergomed (ERGO), Silence Therapeutics (SLN), Neptune Wellness Solutions (NEPT), IMV (IMV), ProMetic Life Sciences (PLI) and Novacyt (NCYT). View all competitors. Who are Arix Bioscience's key executives? Arix Bioscience's management team includes the following people: Dr. Joseph Anderson, CEO & Co-Founder (Age 60)Mr. James Hedley Rawlingson, Chief Financial Officer (Age 51)Sir Christopher Thomas Evans, Consultant (Age 62)Mr. Robert Lyne, COO, Gen. Counsel & Company Sec.Ms. Charlotte Parry, Head of Investor Relations What is Arix Bioscience's stock symbol? Arix Bioscience trades on the London Stock Exchange (LON) under the ticker symbol "ARIX." How do I buy shares of Arix Bioscience? Shares of ARIX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Arix Bioscience's stock price today? One share of ARIX stock can currently be purchased for approximately GBX 103. How big of a company is Arix Bioscience? Arix Bioscience has a market capitalization of £139.68 million and generates £23.47 million in revenue each year. Arix Bioscience employs 14 workers across the globe. What is Arix Bioscience's official website? The official website for Arix Bioscience is arixbioscience.com. How can I contact Arix Bioscience? Arix Bioscience's mailing address is 20 Berkeley Square, LONDON, W1J 6EQ, United Kingdom. The company can be reached via phone at +44-20-72901050. This page was last updated on 9/23/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
